Skin Models

13
Mar

Beyond animal models: The role of human skin in ADME testing

Beyond animal models: The role of human skin in ADME testingADME (Absorption, Distribution, Metabolism, and Excretion) testing plays a vital role in modern drug development by improving candidate selection, reducing failures, enhancing safety assessments, ensuring regulatory compliance, and ultimately saving time and resources in bringing new drugs to market. Traditionally, ADME testing has relied on animal models and in vitro
Read more
17
Feb

FACT SHEET – HairSkin, Human skin model with hair follicles

HairSkin®Human skin model with hair folliclesHairSkin®: the first ex vivo human skin model with mature pilosebaceous units HairSkin® is a cutting-edge ex vivo human skin model, developed with tissue containing fully mature pilosebaceous units. HairSkin® is designed to meet the requirements of both pharmaceutical and cosmetic industries and to empower innovation in dermatology, cosmetics, and personal care. Thanks to a
Read more
10
Feb

From human skin to human data: Advancing immunogenicity testing with human models

From human skin to human data: Advancing immunogenicity testing with human modelsIn a public workshop organized by the FDA-CRCG group, Dr. Nicolas Gaudenzio, CSO of Genoskin, introduced an innovative platform for assessing immune reactions in response to injected substances using human skin explants. His talk, titled "A new in vitro framework for assessing immunogenicity using comprehensive profiling of injectable human
Read more
19
Nov

APPLICATION NOTE – T cell activation and flow cytometry

This application note highlights new comparative data on T cell dynamics in HypoSkin® and InflammaSkin®, generated using flow cytometric analysis.

19
Nov

PROTOCOL – NativeSkin® Analyses

ProtocolNativeSkin® Approved Protocols Please fill in the form below to access the protocols. Need more info? Please contact us! Contact us
21
Oct

WHITE PAPER – HypoSkin® validation data

In this white paper, discover new validation data demonstrating the stability, injectability and immunocompetency of our HypoSkin® model.